Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
about
Temozolomide Resistance in Glioblastoma Cell Lines: Implication of MGMT, MMR, P-Glycoprotein and CD133 ExpressionRole of receptor tyrosine kinases and their ligands in glioblastoma.Immunotherapy of malignant gliomas using autologous and allogeneic tissue cells.Suppression of glioblastoma by targeting the overactivated protein neddylation pathway.Treatment of recurrent metastatic uterine leiomyosarcoma of the spine: a multimodality approach using resection, radiosurgery, and chemotherapy.Stability of temozolomide in solutions aimed for oral treatment prepared from a commercially available powder for infusion.Institutional experience of paediatric high-grade central nervous system tumours: an analysis of 74 patients and review of the literature.Radiation-induced upregulation of telomerase activity escapes PI3-kinase inhibition in two malignant glioma cell lines.Temozolomide-induced myelodysplasia.Establishment of a primary pleomorphic xanthoastrocytoma cell line: in vitro responsiveness to some chemotherapeutics.Crosstalk between glial and glioblastoma cells triggers the "go-or-grow" phenotype of tumor cells.Histone Methylation by Temozolomide; A Classic DNA Methylating Anticancer Drug.The value of temozolomide in combination with radiotherapy during standard treatment for newly diagnosed glioblastoma.Evolutionary basis of a new gene- and immune-therapeutic approach for the treatment of malignant brain tumors: from mice to clinical trials for glioma patients.Temozolomide with or without Radiotherapy in Patients with Newly Diagnosed Glioblastoma Multiforme: A Meta-Analysis.Subcutaneous malignant melanoma of the scalp surgical flap after brain irradiation for anaplastic astrocytoma.Effect of Concomitant Radiochemotherapy on Invasion Potential of Glioblastoma.In vitro evaluation of the cytotoxicity and cellular uptake of CMCht/PAMAM dendrimer nanoparticles by glioblastoma cell models
P2860
Q28550138-FF8DEBD0-7AA4-43A5-B48E-66AF10FD7E34Q33883849-7D90ECF7-A136-48FC-AFC6-164FE241C9B2Q34140756-EEE5D6AB-D318-4BAF-8780-8ED7C979DDACQ36082492-E5493490-EEDE-49EB-9AE0-4F391DEDAB20Q36471540-663FF333-A1A9-4348-B3B4-D6303FC80663Q36855989-CCBA05E3-5F57-4C0B-AD0F-334592B7228CQ36942465-112A9B92-0BF6-42A3-843C-5622E047BDECQ39144903-A88CEEAC-701A-42A2-9337-F549905ABA4EQ39442527-89CCD462-CF5F-4B63-A7A4-EE15DA540AEBQ39532769-71ADE318-54E6-4F76-A842-4461FD9B97A2Q42010694-DF3AD884-59CB-4E72-BD5E-7E9417684FE0Q42108435-A1178819-7A46-47C5-BEE1-CEDF67E11D71Q43953167-8D2103BB-E12C-4CCA-84B3-6A3C70DE7C0CQ47318878-75EE83A2-AF8D-4685-A879-911B34A04113Q48311392-5AA726F3-D01E-4E67-A0CE-4786F0FDC587Q49104758-82C52CB2-B405-407F-9C46-EE9F0AA21A9FQ52148219-14C3DA6A-A2A0-49B0-ABF0-C19AE7CB755BQ57171272-3327F1CC-23C6-4F0F-A655-CBF138928E2C
P2860
Temozolomide with radiation therapy in high grade brain gliomas: pharmaceuticals considerations and efficacy; a review article.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 April 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Temozolomide with radiation th ...... nd efficacy; a review article.
@en
Temozolomide with radiation th ...... nd efficacy; a review article.
@nl
type
label
Temozolomide with radiation th ...... nd efficacy; a review article.
@en
Temozolomide with radiation th ...... nd efficacy; a review article.
@nl
prefLabel
Temozolomide with radiation th ...... nd efficacy; a review article.
@en
Temozolomide with radiation th ...... nd efficacy; a review article.
@nl
P2093
P2860
P1433
P1476
Temozolomide with radiation th ...... and efficacy; a review article
@en
P2093
Andreas Fotineas
Christos Papadimitriou
Demetrios Chaldeopoulos
George Maravelis
Georgios V Koukourakis
Georgios Zacharias
Ivelina Beli
John Kouvaris
Panagiotis Pantelakos
Vassilios Kouloulias
P2860
P304
P356
10.3390/MOLECULES14041561
P407
P577
2009-04-16T00:00:00Z